Academia and industry agreement on a feasibility tool for first-time-in-human clinical trial units.
Saved in:
| Title: | Academia and industry agreement on a feasibility tool for first-time-in-human clinical trial units. |
|---|---|
| Authors: | Moraga P; Clinical Pharmacology Department, La Paz University Hospital, IdiPAZ, Madrid, Spain., Prieto P; Clinical Pharmacology Department, La Paz University Hospital, IdiPAZ, Madrid, Spain., Conradie A; Global Alliance for TB Drug Development (TB Alliance), New York, New York, USA., Benhayoun M; Global Alliance for TB Drug Development (TB Alliance), New York, New York, USA., Rousell V; GlaxoSmithKline, London, UK., Davy M; GlaxoSmithKline, London, UK., Fuhr U; Department of Pharmacology, Faculty of Medicine and University Hospital Cologne, Center for Pharmacology, University of Cologne, Cologne, Germany., Antonijoan Arbos R; Clinical Pharmacology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Drug Research Center, Institut d'Investigació Biomèdica Sant Pau, IIB Sant Pau, Barcelona, Spain.; Pharmacology and Therapeutics Department, Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain., Abad-Santos F; Clinical Pharmacology Department, Hospital Universitario de La Princesa, Instituto Teófilo Hernando, Universidad Autónoma de Madrid (UAM), Instituto de Investigación Sanitaria La Princesa (IP), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain., Portolés A; Clinical Pharmacology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, IdISSC, Madrid, Spain.; Pharmacology and Toxicology Department, School of Medicine, Universidad Complutense de Madrid (UCM), Madrid, Spain., Van Duinen J; QPS Netherlands BV, Groningen, The Netherlands., Carcas AJ; Clinical Pharmacology Department, La Paz University Hospital, IdiPAZ, Madrid, Spain.; Pharmacology Department, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain., Borobia AM; Clinical Pharmacology Department, La Paz University Hospital, IdiPAZ, Madrid, Spain.; Pharmacology Department, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain. |
| Corporate Authors: | ERA4TB Consortium |
| Source: | Clinical and translational science [Clin Transl Sci] 2023 Dec; Vol. 16 (12), pp. 2421-2428. Date of Electronic Publication: 2023 Oct 11. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
